Background: To examine perinatal determinants of the antenatal levels of D-dimers. Methods: Cross-sectional study of 760 low risk pregnant women recruited into five gestational groups. Variables examined in antenatal groups included maternal age, body mass index, parity, smoking, family history venous thromboembolism (VTE) and previous use of the oral contraceptive pill (OCP). Onset of labour and mode of delivery were also examined in the post-natal group.
Introduction
During pregnancy, the risk of venous thromboembolism (VTE) is increased 4-5 fold. 1 VTE is a major cause of maternal morbidity and mortality, accounting for one-third of maternal deaths in the United Kingdom (UK) and has a twofold higher incidence than obstetric haemorrhage, the next most common cause of maternal mortality. 2 D-dimers are specific cross-linked fibrin derivatives produced when fibrin is degraded by plasmin, hence the concentration increases in the presence of thrombolysis. Numerous studies have concluded that the use of D-dimer testing along with clinical assessment in the nonpregnant population is acceptable and assists in reducing the need for admission. [3] [4] [5] D-dimers levels increase throughout gestation due to the hypercoagulable state which occurs in pregnancy. This phenomenon involves an increase in levels of pro-coagulant factors and a decrease in anticoagulant activity, thus, protecting the woman from fatal haemorrhage but pre-disposing her to thromboembolism. 6 D-dimer testing for the diagnosis of VTE in the pregnant woman is not recommended as the reference ranges for non-pregnant patients do not apply. 7 A D-dimer test for VTE would need to be interpreted with a clinical pre-test probability tool, which to date does not exist.
The availability of a sensitive and specific non-invasive screening test for VTE in pregnancy would be very beneficial. We have previously reported gestation-specific reference ranges for D-dimer in healthy pregnant women with a singleton pregnancy using the Auto-Dimer assay. In a cross-sectional study of 760 healthy pregnant women attending for routine care, there was a clear steady increase in median D-dimer concentrations over the gestational period. 7 Additionally, the 95th centile estimates for all gestational time points were above the accepted non-pregnancy normal cut-off concentration (224 ng/ml). The aim of this study was to investigate which clinical features influence D-dimer levels during pregnancy.
Methods
The study was approved by the Clinical Research Ethics Committee of the Cork Teaching Hospitals and all women gave informed written consent. All women who participated were attending Cork University Maternity Hospital, Ireland, a large maternity hospital with approximately 8500 births per year. Recruitment of 760 participants took place over 17 months (June 2009-October 2010).
This was a cross-sectional study of D-dimer levels in healthy women attending for routine antenatal care with a singleton pregnancy free from any underlying health conditions that are known to increase the risk of developing VTE. Women with previous VTE disease and women on current treatment with aspirin or heparin (with the exception of low molecular weight heparin (LMWH) after Caesarean section in the post-natal group) were excluded. Furthermore, women with preeclampsia or other symptoms of uteroplacental dysfunction (for example, severe intrauterine growth restriction and placental abruption), stillbirth and congenital abnormalities were excluded.
Participants provided information pertaining to their general health and that of their immediate family and volunteered for a blood test. Information was included age, parity, body mass index (BMI), smoking history, use of the oral contraceptive pill (OCP) and family history of VTE (defined as a first degree relative with a positive diagnosis of VTE). Extra details obtained from the post-natal group included onset of labour and mode of delivery. Onset of labour was divided into three categories: spontaneous, induction of labour (IOL) and elective Caesarean section (ELCS). Mode of delivery was divided into four categories: normal vaginal delivery (NVD), instrumental vaginal delivery (IVD), ELCS and emergency Caesarean section (EMCS).
Recruitment took place at five difference time points; 512 weeks gestation (n ¼ 164), 19-21 þ 6 weeks (n ¼ 167), 28-36 þ 6 weeks (n ¼ 137) and 38-40 þ 6 weeks (n ¼ 138) gestation and in a day 2 post-natal group (n ¼ 154). Each woman donated one 3 ml blood sample which was drawn into one sodium citrate tube (the mixture was one part sodium citrate solution with nine parts venous blood). The sample was filled exactly to the clearly marked 3 ml indicator on the specimen tube. Overfilled and under filled blood tubes were not tested. Samples were analysed in the Cork University Hospital Haematology laboratory for D-dimer levels within 24 hours of collection. The sample was stored at 2 to 8 C to maintain stability until processing took place.
Samples were analysed using the Bio-Pool auto dimer assay on a fully automated analyser, the Sysmex CA-7000. The Bio-pool auto dimer is an immunoturbidometric assay that uses latex particles coated with antibody against D-dimer. In the presence of D-dimer, particles join to form larger aggregates. The increase in scattered light is proportional to the amount of D-dimer in the sample. 8 All laboratories determine internal cut-off points in applying a D-dimer assay to aid in the diagnosis of VTE. The recommended nonpregnancy cut-off established by the local haematology laboratory in Cork University Hospital of this assay was 224 ng/ml.
Statistical analysis was performed using SPSS 16.0. Descriptive statistics such as median was calculated for each variable. Kruskal Wallis test was performed to compare results to variables within each group to test for significant findings. P value 50.05 was considered statistically significant. Post-natal D-dimer levels according to mode and onset of delivery were compared using Mann-Whitney test. Crude and adjusted linear regression models were performed to examine the association between maternal age, BMI, parity, smoking, family history of VTE and OCP and D-dimer levels from the four antenatal time points using Stata 10.0. The linear regression models accounted for the gestational age group using the cluster option in Stata.
Results
The average age of the women recruited was 25 years (SD ¼ 12.4) with a range from 18 to 44 years. The highest number of participants was in the 25-30 years of age group. The average BMI overall was 25.0 and 5% (n ¼ 41) of women were recorded as obese. Four hundred and fifty five (62.3%) of women recruited were multiparous. The group was largely made up of non-smokers 75% (n ¼ 571) with 12% (n ¼ 88) claiming to having ceased smoking during the current pregnancy. Further details regarding baseline characteristics of all study participants are detailed in Table 1 . Table 1 also presents the results of the crude and adjusted linear regression analysis which examined the association between smoking, BMI, maternal age, parity, family history of VTE and OCP use including data from the four pregnant groups. In the adjusted analysis, women categorized as obese had a significantly higher mean D-dimer when compared to those who were of normal weight (197.3, CI 26. 1, 368.4) . Also women with no family history of VTE had a significantly higher mean D-dimer than those with no history (137.7, CI 18.0, 258.5).
Of the clinical variables examined in the antenatal groups, previous OCP use was the only one associated with a significant difference in D-dimer levels at 38-40 weeks plus 6 days. In this group, 73% (n ¼ 101) of women had taken the OCP prior to pregnancy and 25% (n ¼ 34) had not. Unexpectedly, D-dimer levels were significantly lower in the group that had a history of taking the OCP when compared to those that had never taken it (median D-dimer level 637 ng/ml, Inter Quartile Range (IQR) ¼ 363.5 compared to in 745.5 ng/ml, IQR ¼ 225.8) P ¼ 0.027 (Figure 1) .
In the post-natal group, median D-dimer levels were significantly lower in the ELCS group in comparison to spontaneous onset and IOL ( Table 2 ). The findings of the comparisons of the various modes of delivery are outlined in Table 3 . Median D-dimer levels were significantly lower in women who had an ELCS when compared to NVD and IVD, 403 ng/ml compared to 524 ng/ml (P ¼ 0.008) and 700 ng/ml (P ¼ 0.007) respectively). There was also a significant difference in the median D-dimer level of those delivered by EMCS versus ELCS (548 ng/ml, IQR ¼ 208 v 403 ng/ml, IQR ¼ 145, P ¼ 0.015). Finally, there was also a significant difference seen between the median D-dimer in primiparous women versus multiparous in the day 2 post-natal group (P ¼ 0.015).
Discussion

Main findings
This study shows that during pregnancy, the only apparent variable influencing D-dimer levels in our study was a history of taking the OCP in women in the 38-40 weeks gestation group. In the day 2 post-natal group, it shows D-dimer levels were significantly higher in primiparous in comparison to multiparous. It also shows that D-dimer is raised in women post EMCS in comparison to ELCS and women post NVD and IVD when compared to ELCS as well as being raised in spontaneous and induction onset of labour in comparison to ELCS.
A previous study by Epiney et al. 9 has investigated D-dimer levels during delivery and in the post-natal period. The present study found that women post EMCS had a significantly higher D-dimer level than ELCS. In contrast, Epiney et al. found that women who underwent EMCS did not have significantly higher levels of D-dimers compared to women who had a vaginal birth although the mean difference in both studies was in the same direction (À145 ng/ml vs À464 ng/ml). We found no significant difference in mean D-dimer level at day 2 postpartum between women who were post an IVD and NVD while Epiney et al. found a significant difference in mean D-dimer level at day 3 postpartum, but again the mean difference for this comparison was in the same direction (À176 ng/ml vs À318 ng/ml).
It should be noted that Epiney et al. used a different assay and indeed found that D-dimer levels were higher in all patient categories compared with the present study. Therefore, the apparent inconsistent findings between the present study and Epiney's are likely due to lack of adequate statistical power for some of the statistical tests rather than true difference.
As part of this study, we aimed to investigate the effects of age, smoking, BMI, parity, OCP use, family history VTE, onset of delivery and mode of delivery on D-dimer levels during pregnancy and two days postpartum across a range of gestations.
In the antenatal period, in the late pregnancy group (38-40 weeks plus 6 days), women who had a history of taking the OCP had a significantly lower D-dimer level than those that had not (P ¼ 0.027). This finding is at odds with previous work which has reported that acute exposure to the OCP increases D-dimer levels. 10, 11 We cannot explain why a remote history of OCP use led to a lower D-dimer level at just this one time point in late pregnancy. It is unlikely that OCP exposure leads to long-term changes in the haemostatic system, and even if that were the case, the expectation would be for D-dimer levels to increase. This finding is more likely to be due to confounding unknown common clinical features. It may be that women at higher risk of VTE were not offered the OCP as a form of contraception.
In the day 2 post-natal group, there were no significant differences in the D-dimer levels when the variables age, smoking, BMI, OCP use and family history VTE were examined. The median D-dimer level was higher in primiparous women versus multiparous women. This is an intriguing finding and to our knowledge, this has not been previously described in normal pregnancies. First pregnancies are different to second pregnancies, particularly with regard to outcomes. Disorders of placentation (fetal growth restriction and pre-eclampsia) occur more frequently in first pregnancies. 12 D-dimer levels (and other makers of a hyper-coagulable state) increase in women with pre-eclampsia. 13, 14 One might speculate that the increased D-dimer levels seen in the present study reflect a subclinical difference in placentation between first and second pregnancies but this will need to be assessed in any future studies.
When onset of labour was examined, the median D-dimer levels were significantly lower in the ELCS group in comparison to spontaneous onset and IOL. When the mode of delivery was examined, the median D-dimer levels were significantly lower in those that had an ELCS when compared to NVD and IVD. This possibly reflects the practice of routine administration of LMWH to women post Caesarean section and is in line with previous studies which have shown that treatment with heparin leads to lower D-dimer levels. 15 Interestingly, median D-dimer level was higher in women who underwent EMCS versus ELCS. This may reflect the effect of a preceding labour, compounded by dehydration or possibly increased intraoperative blood loss with EMCS versus ELCS. We were unable to extrapolate data to support this from the present study and this requires further research.
Strengths and limitations
This study represents one of the largest and most comprehensive studies in this area. The cross-sectional design provided a snapshot of this pregnant population. It was set against strict inclusion and exclusion criteria. It was conducted using strict Standard of Practice manuals for sample processing and assay performance. It would appear to have the largest number of recruits for a study of this type to date. It also covers a wide variety of variables in a number of gestational time points. The study cohort was made up of a very homogenous group; this may also be regarded as a limitation. Other limitations of the study included the use of LMWH post-natally, this made determination of the effect of mode of delivery impossible. Also, other clinical variables that were not collected such as use of over the counter medications and diet may be influential and were not examined.
Conclusion
This was the first study to have tested variables in antenatal recruits, age, BMI, smoking, parity and OCP use. When comparisons were performed, there were no significance differences in D-dimer levels identified until the last three weeks of pregnancy in the 38-40 week group and the day 2 post-natal group. When each time point was analysed, no difference was seen within the variable age, BMI and smoking. In the 38-40 weeks group, the women who had a history of OCP use had a lower median D-dimer level than those who had no history. The post-natal analysis showed significant differences in D-dimer levels between primiparous and multiparous women as well as those post ELCS in comparison to spontaneous and induced labour. These results are useful in the continued study of the role of D-dimer levels in the diagnosis of VTE in pregnancy. Possible further investigation would be to conduct a large prospective study including women with a diagnosis of VTE and women with disorders of placentation in pregnancy. This would aid in the investigation of the usefulness of previously recommended cut offs for D-dimer in pregnancy. 7 
